Universal Biosensors Inc
Company Profile
Business description
Universal Biosensors Inc is biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride and Xprecia Prime which are medical devices, Sentia non-medical wine testing products, and Petrackr which is a blood glucose test used in cats and dogs. It has one reportable segment: specialist biosensors company. Geographically, the company generates majority of its revenue from Australia and rest from Americas, Europe and other markets.
Contact
1 Corporate Avenue
RowvilleVIC3178
AUST: +61 392139000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
76
Stocks News & Analysis
stocks
3 global ‘buy the dip’ candidates with wide moats
stocks
What next for Nine Entertainment after Domain payout?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,128.70 | 18.10 | 0.20% |
CAC 40 | 7,825.24 | 1.72 | 0.02% |
DAX 40 | 23,698.15 | 5.50 | -0.02% |
Dow JONES (US) | 45,834.22 | 273.78 | -0.59% |
FTSE 100 | 9,283.29 | 14.29 | -0.15% |
HKSE | 26,388.16 | 301.84 | 1.16% |
NASDAQ | 22,141.10 | 98.03 | 0.44% |
Nikkei 225 | 44,768.12 | 395.62 | 0.89% |
NZX 50 Index | 13,227.90 | 1.25 | -0.01% |
S&P 500 | 6,584.29 | 3.18 | -0.05% |
S&P/ASX 200 | 8,864.90 | 22.00 | 0.25% |
SSE Composite Index | 3,870.60 | 4.71 | -0.12% |